Currently out of the existing stock ratings of Trevor Allred, 12 are a BUY (100%).

Trevor Allred

Work Performance Price Targets & Ratings Chart

Analyst Trevor Allred, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 75% that have a potential upside of 27.61% achieved within 96 days.

Trevor Allred’s has documented 24 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on LGND, Ligand Pharmaceuticals at 27-Feb-2026.

Wall Street Analyst Trevor Allred

Analyst best performing recommendations are on DNTH (DIANTHUS THERAPEUTICS).
The best stock recommendation documented was for DNTH (DIANTHUS THERAPEUTICS) at 11/6/2025. The price target of $62 was fulfilled within 118 days with a profit of $25.57 (70.19%) receiving and performance score of 5.95.

Average potential price target upside

BBIO BridgeBio Pharma DNTH Dianthus Therapeutics INVA Innoviva LGND Ligand Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Feb-2020

$96

$15.91 (19.87%)

$106

Buy Since 06-Jan-2026

$98

$17.91 (22.36%)

$98

Hold Since 19-May-2026

$82

$1.91 (2.38%)

$54

Show more analysts

Please expand the browser size to see the chart

Which stock is Trevor Allred is most bullish on?

Potential upside of $0.91 has been obtained for BBIO (BRIDGEBIO PHARMA)

Which stock is Trevor Allred is most reserved on?

Potential downside of -$10.54 has been obtained for LGND (LIGAND PHARMACEUTICALS)

What Year was the first public recommendation made by Trevor Allred?

On 2024

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?